ID

24378

Descrizione

NCT00079911 Study ID 100181 Clinical Study ID HS2100181 Study Title: An International, Randomized, Double-Blind, Placebo-Controlled Study of Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons with CD4+ lymphocyte count <100 cells/mm3. Patient Level Data Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00079911 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 4 Study Recruitment Status: Terminated Generic Name: valaciclovir Trade Name: ZELITREX,Valtrex,RAPIVIR,Novirus Study Indication: Genital Herpes; HIV infection

Keywords

versioni (1)
  1. 30/07/17 30/07/17 -
Titolare del copyright

GlaxoSmithKline

Caricato su

30 luglio 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

GSK Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons INVESTIGATIONAL PRODUCT DISCONTINUATION NCT00079911

Inglese

GSK Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons INVESTIGATIONAL PRODUCT DISCONTINUATION NCT00079911

1 moduli  
Study administration
Descrizione

Study administration

Subject Identifier
Descrizione

Subject Identifier

Tipo di dati

integer

Alias
UMLS CUI [1]
C2348585
INVESTIGATIONAL PRODUCT DISCONTINUATION
Descrizione

INVESTIGATIONAL PRODUCT DISCONTINUATION

Was the investigational product stopped pennanently before the end of the scheduled treatment period?
Descrizione

early discontinuation

Tipo di dati

text

Alias
UMLS CUI [1]
C4288399
If Yes, check the primary reason the investigational product was stopped:
Descrizione

reason drug discontinuation

Tipo di dati

text

Alias
UMLS CUI [1,1]
C4288399
UMLS CUI [1,2]
C0392360
Ritorna all'inizio della pagina

Similar models

GSK Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons INVESTIGATIONAL PRODUCT DISCONTINUATION NCT00079911

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Study administration
Subject Identifier
Item
Subject Identifier
integer
C2348585 (UMLS CUI [1])
Item Group
INVESTIGATIONAL PRODUCT DISCONTINUATION
Item
Was the investigational product stopped pennanently before the end of the scheduled treatment period?
text
C4288399 (UMLS CUI [1])
early discontinuation
Code List
Was the investigational product stopped pennanently before the end of the scheduled treatment period?
CL Item
Yes (Y)
CL Item
No (N)
Item
If Yes, check the primary reason the investigational product was stopped:
text
C4288399 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
reason drug discontinuation
Code List
If Yes, check the primary reason the investigational product was stopped:
CL Item
Adverse event (record details on the Non-Serious Adverse Event or Serious Adverse Event (1)
CL Item
pages as appropriate) (pages as appropriate))
CL Item
Lost to follow-up (2)
CL Item
Protocol violation (3)
CL Item
Subject decided to withdraw from the study (4)
CL Item
Other. specify (Z)
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial